Company / Free Cash Flow per Share
CG Oncology, Inc. Free Cash Flow per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.71
FY2025
5-year range
-$1.71 / -$1.26
FY2024-FY2025
Trend
-35.7%
vs FY2024
Sector context
#126 of 193
Health Care
What the data says
At $-1.71, CG Oncology, Inc.'s free cash flow per share ranks #126 of 193 in the Health Care sector.
Based on SEC 10-K filings.
-1.71 in FY2025.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#126 of 193 in Health CareTop 65% of 193This company -$1.71 Sector average -$19.72
▼
+91.3% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 35.7% year-over-year.
- Ranks #126 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.71 | -35.7% |
| FY2024 | -$1.26 | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026